DNA methylation profile during multistage progression of pulmonary adenocarcinomas

Virchows Archiv

Volumn 459, Issue 2, 2011, Pages 201-211

  Chung, Jin Haeng ^a,b   Lee, Hyun Ju ^a,b   Kim, Baek Hui ^c   Cho, Nam Yun ^b   Kang, Gyeong Hoon ^b,d  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

Adenocarcinoma; AIS; CpG island; DNA methylation; Lung cancer

Indexed keywords

CADHERIN; CADHERIN 13; CELLULAR RETINOIC ACID BINDING PROTEIN 1; CYCLIN D2; HOMEODOMAIN PROTEIN; INTEGRIN; MEMBRANE PROTEIN; METALLOTHIONEIN 1 G; METALLOTHIONEIN I; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PROENKEPHALIN; PROTEIN BCL 2; PROTEIN DLEC1; PROTEIN HOMEOBOX A1; PROTEIN INTEGRIN ALPHA 4; PROTEIN RETINOIC ACID RECEPTOR RESPONDER 1; PROTEIN SEIZURE RELATED 6 HOMOLOG; PROTEIN TMEFF2; RETINOIC ACID BINDING PROTEIN; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR BETA; SECRETED FRIZZLED RELATED PROTEIN 5; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR HOXA10; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATYPICAL ADENOMATOUS HYPERPLASIA; CANCER GROWTH; CANCER STAGING; CARCINOMA IN SITU; CPG ISLAND; DNA METHYLATION; FEMALE; HUMAN; HUMAN TISSUE; HYPERPLASIA; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; DNA, NEOPLASM; EPIGENESIS, GENETIC; FEMALE; HUMANS; HYPERPLASIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROMOTER REGIONS, GENETIC;

EID: 80052424755     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-011-1079-9     Document Type: Article

References (38)

1. M Mori SK Rao HH Popper PT Cagle AE Fraire 2001 Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung Mod Pathol 14 72 84 11235908 10.1038/modpathol. 3880259 1:STN:280:DC%2BD3M7nsVKjtw%3D%3D (Pubitemid 32173389)
2. J Soh S Toyooka S Ichihara H Asano N Kobayashi H Suehisa H Otani H Yamamoto K Ichimura K Kiura AF Gazdar H Date 2008 Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung J Thorac Oncol 3 340 347 18379350 10.1097/JTO.0b013e318168d20a (Pubitemid 351489472)
3. S Lantuejoul D Salameire C Salon E Brambilla 2009 Pulmonary preneoplasia-sequential molecular carcinogenetic events Histopathology 54 43 54 19187179 10.1111/j.1365-2559.2008.03182.x
4. SB Yoo JH Chung HJ Lee CT Lee S Jheon SW Sung 2010 Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung J Thorac Oncol 5 964 969 20512074
5. K Sugio Y Kishimoto AK Virmani JY Hung AF Gazdar 1994 K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas Cancer Res 54 5811 5815 7954406 1:CAS:528:DyaK2cXmvFyitb8%3D (Pubitemid 24375211)
6. Y Yoshida T Shibata A Kokubu K Tsuta Y Matsuno Y Kanai H Asamura R Tsuchiya S Hirohashi 2005 Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung Lung Cancer 50 1 8 15950315 10.1016/j.lungcan.2005.04.012 (Pubitemid 41297463)
7. H Sakamoto J Shimizu Y Horio R Ueda T Takahashi T Mitsudomi Y Yatabe 2007 Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas J Pathol 212 287 294 17534846 10.1002/path.2165 1:CAS:528:DC%2BD2sXosVyms7o%3D (Pubitemid 47010062)
8. Y Sakuma S Matsukuma M Yoshihara Y Nakamura K Noda H Nakayama Y Kameda E Tsuchiya Y Miyagi 2007 Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations Am J Clin Pathol 128 100 108 17580276 10.1309/WVXFGAFLAUX48DU6 1:CAS:528:DC%2BD2sXot1Kqtrw%3D (Pubitemid 47121721)
9. K Ikeda H Nomori Y Ohba H Shibata T Mori Y Honda K Iyama T Kobayashi 2008 Epidermal growth factor receptor mutations in multicentric lung adenocarcinomas and atypical adenomatous hyperplasias J Thorac Oncol 3 467 471 18448997 10.1097/JTO.0b013e31816b4b14 (Pubitemid 351630272)
10. G Sartori A Cavazza F Bertolini L Longo A Marchioni M Costantini F Barbieri M Migaldi G Rossi 2008 A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis Am J Clin Pathol 129 202 210 18208799 10.1309/THU13F3JRJVWLM30 1:CAS:528:DC%2BD1cXitlGrt7o%3D (Pubitemid 352029309)
11. JH Chung G Choe S Jheon SW Sung TJ Kim KW Lee JH Lee CT Lee 2009 Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread J Thorac Oncol 4 1490 1495 19844187 10.1097/JTO.0b013e3181bc9731
12. A Horiike H Kimura K Nishio F Ohyanagi Y Satoh S Okumura Y Ishikawa K Nakagawa T Horai M Nishio 2007 Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancer Chest 131 1628 1634 17565015 10.1378/chest.06-1673 1:CAS:528:DC%2BD2sXotVCqur0%3D (Pubitemid 46981613)
13. Y Sekido KM Fong JD Minna 2003 Molecular genetics of lung cancer Annu Rev Med 54 73 87 12471176 10.1146/annurev.med.54.101601.152202 1:CAS:528: DC%2BD3sXit1ejs7k%3D (Pubitemid 37386386)
14. Y Shu T Iijima W Sun J Kano T Ishiyama C Okubo Y Anami R Tanaka S Fukai M Noguchi 2006 The ACIN1 gene is hypermethylated in early stage lung adenocarcinoma J Thorac Oncol 1 160 167 17409846 10.1097/01243894-200602000- 00010 (Pubitemid 47164004)
15. T Kubo H Yamamoto K Ichimura M Jida T Hayashi H Otani K Tsukuda Y Sano K Kiura S Toyooka 2009 DNA methylation in small lung adenocarcinoma with bronchioloalveolar carcinoma components Lung Cancer 65 328 332 19144441 10.1016/j.lungcan.2008.12.001
16. WB Isaacs GS Bova RA Morton MJ Bussemakers JD Brooks CM Ewing 1994 Molecular biology of prostate cancer Semin Oncol 21 514 521 7939745 1:STN:280:DyaK2M%2Fis1SjsQ%3D%3D (Pubitemid 24329128)
17. SB Baylin JG Herman 2000 DNA hypermethylation in tumorigenesis: epigenetics joins genetics Trends Genet 16 168 174 10729832 10.1016/S0168- 9525(99)01971-X 1:CAS:528:DC%2BD3cXit1Sqsbg%3D (Pubitemid 30169152)
18. S Lee HJ Lee JH Kim HS Lee JJ Jang GH Kang 2003 Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis Am J Pathol 163 1371 1378 14507645 10.1016/S0002-9440(10)63495-5 1:CAS:528:DC%2BD3sXotlegtr0%3D (Pubitemid 37175085)
19. SB Hake A Xiao CD Allis 2004 Linking the epigenetic 'language' of covalent histone modifications to cancer Br J Cancer 90 761 769 14970850 10.1038/sj.bjc.6601575 1:CAS:528:DC%2BD2cXht12itbw%3D (Pubitemid 38406583)
20. NY Cho JH Kim KC Moon GH Kang 2009 Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm Virchows Arch 454 17 23 19048291 10.1007/s00428-008-0706-6 1:CAS:528:DC%2BD1cXhsFSrurvF
21. PA Jones SB Baylin 2002 The fundamental role of epigenetic events in cancer Nat Rev Genet 3 415 428 12042769 10.1038/nrg962 1:CAS:528: DC%2BD38XksFOmsrw%3D (Pubitemid 34587077)
22. JF Costello MC Fruhwald DJ Smiraglia LJ Rush GP Robertson X Gao FA Wright JD Feramisco P Peltomaki JC Lang DE Schuller L Yu CD Bloomfield MA Caligiuri A Yates R Nishikawa H Su Huang NJ Petrelli X Zhang MS O'Dorisio WA Held WK Cavenee C Plass 2000 Aberrant CpG-island methylation has non-random and tumour-type-specific patterns Nat Genet 24 132 138 10655057 10.1038/72785 1:CAS:528:DC%2BD3cXhtFCgsb0%3D (Pubitemid 30094712)
23. M Esteller PG Corn SB Baylin JG Herman 2001 A gene hypermethylation profile of human cancer Cancer Res 61 3225 3229 11309270 1:CAS:528: DC%2BD3MXjtFSjt7g%3D (Pubitemid 32695003)
24. JA Tsou JA Hagen CL Carpenter IA Laird-Offringa 2002 DNA methylation analysis: a powerful new tool for lung cancer diagnosis Oncogene 21 5450 5461 12154407 10.1038/sj.onc.1205605 1:CAS:528:DC%2BD38XlslSqt7g%3D (Pubitemid 34983481)
25. SA Belinsky 2004 Gene-promoter hypermethylation as a biomarker in lung cancer Nat Rev Cancer 4 707 717 15343277 10.1038/nrc1432 1:CAS:528: DC%2BD2cXntFCmsbY%3D (Pubitemid 39215069)
26. JA Tsou LY Shen KD Siegmund TI Long PW Laird CK Seneviratne MN Koss HI Pass JA Hagen IA Laird-Offringa 2005 Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung Lung Cancer 47 193 204 15639718 10.1016/j.lungcan.2004.08.003 (Pubitemid 40082162)
27. DS Shames L Girard B Gao, et al. 2006 A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies PLoS Med 3 e486 17194187 10.1371/journal.pmed.0030486 (Pubitemid 46028510)
28. WD Travis E Brambilla M Noguchi, et al. 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multi-disciplinary Classification of Lung Adenocarcinoma J Thorac Oncol 6 244 285 21252716 10.1097/JTO.0b013e318206a221
29. DJ Weisenberger M Campan TI Long M Kim C Woods E Fiala M Ehrlich PW Laird 2005 Analysis of repetitive element DNA methylation by MethyLight Nucleic Acids Res 33 6823 6836 16326863 10.1093/nar/gki987 1:CAS:528:DC%2BD2MXhtlagtbfO (Pubitemid 41830488)
30. GH Kang S Lee NY Cho T Gandamihardja TI Long DJ Weisenberger M Campan PW Laird 2008 DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis Lab Invest 88 161 170 18158559 10.1038/labinvest.3700707 1:CAS:528:DC%2BD1cXhtVCrurk%3D (Pubitemid 351161274)
31. S Ogino T Kawasaki M Brahmandam M Cantor GJ Kirkner D Spiegelman GM Makrigiorgos DJ Weisenberger PW Laird M Loda CS Fuchs 2006 Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis J Mol Diagn 8 209 217 16645207 10.2353/jmoldx.2006.050135 1:CAS:528:DC%2BD28XltlKlsrg%3D (Pubitemid 43811244)
32. BH Kim NY Cho SH Shin HJ Kwon JJ Jang GH Kang 2009 CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma Virchows Arch 455 343 351 19763613 10.1007/s00428-009-0829-4 1:CAS:528:DC%2BD1MXhtlagt7fN
33. S Lee KS Hwang HJ Lee JS Kim GH Kang 2004 Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia Lab Invest 84 884 893 15122305 10.1038/labinvest.3700108 1:CAS:528:DC%2BD2cXmtFymtb0%3D (Pubitemid 38833248)
34. GH Kang S Lee JS Kim HY Jung 2003 Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis Lab Invest 83 635 641 12746473 1:CAS:528:DC%2BD3sXjtlKjs7s%3D (Pubitemid 36618042)
35. N Sato N Fukushima RH Hruban M Goggins 2008 CpG island methylation profile of pancreatic intraepithelial neoplasia Mod Pathol 21 238 244 18157091 10.1038/modpathol.3800991 1:CAS:528:DC%2BD1cXisVKmt70%3D (Pubitemid 351304281)
36. M Yamanaka M Watanabe Y Yamada A Takagi T Murata H Takahashi H Suzuki H Ito H Tsukino T Katoh Y Sugimura T Shiraishi 2003 Altered methylation of multiple genes in carcinogenesis of the prostate Int J Cancer 106 382 387 12845678 10.1002/ijc.11227 1:CAS:528:DC%2BD3sXlvF2hsr8%3D (Pubitemid 36870401)
37. M Noguchi A Morikawa M Kawasaki Y Matsuno T Yamada S Hirohashi H Kondo Y Shimosato 1995 Small adenocarcinoma of the lung. Histologic characteristics and prognosis Cancer 75 2844 2852 7773933 10.1002/1097-0142(19950615)75:12<2844:: AID-CNCR2820751209>3.0.CO;2-# 1:STN:280:DyaK2M3pt1amtA%3D%3D
38. HJ Lee G Choe S Jheon SW Sung CT Lee JH Chung 2010 CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification J Thorac Oncol 5 649 657 20354454